Aventis Pharma Deutschland GmbH v Kohlpharma GmbH and MTK Pharma Vertriebs-GmbH.

Core Citations

REPORTED OPINION OF in

• [2003] All ER EC 78
• Case C-377/98
• 70 BMLR 12

[See more]

• [2002] LS Law TM 02
• [2003] ETMR 11
• [2002] 3 CMLR 24
• [2002] ECR I-7761
• 61998CJ0377

WORK EXPRESSION OF in

• [2003] All ER EC 78
• Case C-377/98
• 70 BMLR 12

[See more]

• [2002] LS Law TM 02
• [2003] ETMR 11
• [2002] 3 CMLR 24
• [2002] ECR I-7761
• 61998CJ0377
• Aventis Pharma Deutschland GmbH v Kohlpharma GmbH and MTK Pharma Vertriebs-GmbH.

This document cites

• MPA Pharma GmbH contra Rhône-Poulenc Pharma GmbH.
• Merck, Sharp & Dohme GmbH v Paranova Pharmazeutika Handels GmbH.
• Council Directive 92/27/EEC of 31 March 1992 on the labelling of medicinal products for human use and on package leaflets
• Council Directive 83/570/EEC of 26 October 1983 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products
• Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products



See all quotations

• Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products
• Council Directive 89/341/EEC of 3 May 1989 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products
• Treaty establishing the European Community